Jun 08, 2023 04:01 PM
Parmax Pharma Ltd
SECTOR : Pharmaceuticals | BSE :540359 |
Equity Capital: 5.96 Cr FV: 10.00
|Period||MF Net Purchase / (sold)||FII Net|
Incorporated as a public limited company in Nov.`94, Parmax Pharma (PPL) was promoted by Jayantilal S Dhol, Purushottam J Bhalodi and Prabhudas D Hansalpara. PPL set up a plant to manufacture and market bulk drugs like amoxycillin tri-hydrate, ampicillin tri-hydrate, cephalexin mono hydrate and nalidixic acid, at Hadamtala, Gujarat, with an installed capacity of 96 tpa. Its Antibiotic project has been fully implemented from 31st May`97, and the non-Antibiotic products project is under final stage of implementation.
Plot No 20 Survey No 52, Tal Kotda Sangani Hadamtala, Rajkot, Gujarat, 360311
Mavji Haribhai Sec & Serv P Lt
|AGM Date (Month)||:||Oct|
|Face Value Equity Shares||:||10|
|Market Lot Equity Shares||:||1|
|Book Closure Date (Month)||:||Oct|
You can buy Parmax Pharma Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Parmax Pharma Ltd Share.
Company share prices and volatile and keep changing according to the market conditions. As of Jun 08, 2023 04:01 PM the closing price of Parmax Pharma Ltd was ₹ 30.84.
Market capitalization or market cap is determined by multiplying the current market price of a company’s shares with the total number of shares outstanding. As of Jun 08, 2023 04:01 PM, the market cap of Parmax Pharma Ltd stood at ₹ 11.54.
The latest PE ratio of Parmax Pharma Ltd as of Jun 08, 2023 04:01 PM is 0
The latest PB ratio of Parmax Pharma Ltd as of Jun 08, 2023 04:01 PM is 0.45
The 52-week high of Parmax Pharma Ltd is ₹ 57.60 while the 52-week low is ₹ 26.35